Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
United Therapeutics Corporation | UTHR | 7.17K | $3.89M |
BeOne Medicines AG | ONC | 12.27K | $3.5M |
Kiniksa Pharmaceuticals International, plc | KNSA | 18.87K | $1.21M |
Roivant Sciences Ltd. | ROIV | 25.62K | $906.8K |
Revolution Medicines, Inc. | RVMD | 51.05K | $9.56M |
Axsome Therapeutics, Inc. | AXSM | 53.92K | $13.2M |
Tonix Pharmaceuticals Holding Corp. | TNXP | 63.65K | $812.15K |
Vaxcyte, Inc. | PCVX | 66.79K | $3.88M |
Protara Therapeutics, Inc. | TARA | 121.46K | $463.97K |
MapLight Therapeutics, Inc. | MPLT | 125.43K | $4.5M |
Definium Therapeutics, Inc. | DFTX | 188.28K | $8.86M |
Immunovant, Inc. | IMVT | 208.37K | $8.03M |
Aclaris Therapeutics, Inc. | ACRS | 257.68K | $1.36M |
Celldex Therapeutics, Inc. | CLDX | 287.58K | $10.7M |
Cogent Biosciences, Inc. | COGT | 343.28K | $13.29M |
ORIC Pharmaceuticals, Inc. | ORIC | 406.08K | $4.4M |
Genmab A/S | GMAB | 430.6K | $11.83M |
Trevi Therapeutics, Inc. | TRVI | 524.22K | $9.78M |
Vir Biotechnology, Inc. | VIR | 853.68K | $8.7M |